Eli Lilly and Company (LLY)

Index:

S&P 100

$ 883.88
   
  • Change Today:
    $0.00
  • 52 Week High: $891.46
  • 52 Week Low: $434.70
  • Currency: US Dollars
  • Shares Issued: 949.78m
  • Volume: 19,925
  • Market Cap: $839,492m
  • RiskGrade: 179

Latest ShareCast News

Roche sees positive results from weight-loss trials

By Abigail Townsend

Date: Thursday 16 May 2024

(Sharecast News) - Roche reported positive trial results for its experimental weight loss treatment on Thursday, sending shares in the Swiss drugs group higher.

Eli Lilly hikes sales guidance by $2bn, shares jump

By Benjamin Chiou

Date: Tuesday 30 Apr 2024

(Sharecast News) - Shares in Eli Lilly jumped on Wall Street on Tuesday after the American pharma giant beat quarterly profit forecasts and hiked its full-year sales guidance by $2bn, helped by surging demand for its weight-loss drug Zepbound.

Eli Lilly weight-loss drug 'significantly' reduces sleep apnoea

By Abigail Townsend

Date: Wednesday 17 Apr 2024

(Sharecast News) - Eli Lily's weight-loss drug tirzepatide has been shown to "significantly" reduce sleep apnoea severity, the US drugs giant said on Wednesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 883.88
Change Today $ 0.00
% Change 0.00 %
52 Week High $891.46
52 Week Low $434.70
Volume 19,925
Shares Issued 949.78m
Market Cap $839,492m
RiskGrade 179

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2024

Time Volume / Share Price
0 @ $0.00

Top of Page